ArticleNature communications2025
Differential gut transmission of IncP plasmid clades involving hypervirulent Klebsiella pneumoniae reveals plasmid-specific ecological adaptation.
Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- ElevatedEmerging microbes & infections · 2026Article
- Article
- AllTheBacteria: a community resource empowers biology and discovers novel peptide antibiotics.bioRxiv : the preprint server for biology · 2026Article
- Digital health technology empowering China's community full life cycle health management.Digital healthReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
Abstract
Conjugative plasmids can drive the global spread of antimicrobial resistance (AMR) in Enterobacterales. Hypervirulent Klebsiella pneumoniae (hvKp) increasingly acquire AMR plasmids, raising concern about convergent hypervirulent drug-resistant clones. Yet little is known about plasmid transmission dynamics in hvKp. Using an antibiotic-perturbed murine gut model with hvKp and human commensal E. coli, we discover that broad-host range IncP plasmids belonging to different phylogenetic branches (clade I (PTU-P1) and clade II (PTU-P2)) transfer differentially in the gut, mirroring the higher prevalence of PTU-P2 plasmids in human-associated samples. Statistical modelling and experimental results show that secondary transfer by transconjugants sustains gut transmission without continuous donor input. Furthermore, the hvKp capsule exerts a modest effect on transfer in vivo compared to in vitro aerobic conditions. Under anaerobic conditions, hvKp capsule mucoviscosity is markedly reduced, and PTU-P2 plasmids conjugate more efficiently than PTU-P1 counterparts. Our findings reveal that the hypermucoviscous capsule may not substantially impede gene exchange in the gut where microenvironments shape plasmid transfer dynamics, highlighting the pitfalls of extrapolating in vitro data to relevant ecological niches. Our work also emphasizes the high-risk nature of gut-adapted PTU-P2 plasmids and the ease with which hvKp can acquire them, underscoring the need for continued surveillance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.